Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis - Concepedia

Concepedia

Publication | Closed Access

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis

82

Citations

21

References

2013

Year

José Antonio López Mira, Antonio Rivero‐Juárez, Luís F. López‐Cortés, J.A. Girón González, Francisco Téllez, Ignacio de los Santos, Juan Macı́as, Dolores Merino, Manuel Márquez, Maria José Ríos-Villegas,

Clinical Infectious Diseases

Abstract

The achievement of SVR following peg-IFN plus RBV markedly reduces the incidence of liver-related decompensation and the overall mortality in HIV/HCV-coinfected patients with compensated cirrhosis.

References

	Year	Citations

Page 1